Here are what the editors at HealthDay consider to be the most important developments in Allergy for July 2020. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice.
Telemedicine Use Explodes During COVID-19 Pandemic
FRIDAY, July 31, 2020 (HealthDay News) — The emergence of telemedicine has accelerated during the coronavirus pandemic. HD Live! sat down with Rujuta Saksena, M.D., an oncologist at Overlook Medical Center in Summit, New Jersey, and Ateev Mehrotra, M.D., associate professor of health care policy at Harvard Medical School in Boston, to discuss the future of telemedicine and its impact on health care.
Sex Differences in Income Vary With Proportion of Male Doctors
FRIDAY, July 31, 2020 (HealthDay News) — For surgical and nonsurgical specialists, sex differences in income vary with the proportion of male physicians in a practice, according to a study published online July 30 in The BMJ.
Postmarketing Surveillance Helps Identify Vaccine Safety Issues
TUESDAY, July 28, 2020 (HealthDay News) — A review of all safety-related labeling changes for FDA-approved vaccines during a 20-year period shows vaccines are largely safe, and many of the safety issues are identified through postmarketing surveillance, according to a study published online July 28 in the Annals of Internal Medicine.
CDC Guidance Issued for Testing, Management of HCP Exposed to Hep C
FRIDAY, July 24, 2020 (HealthDay News) — In a U.S. Centers for Disease Control and Prevention guidance report, published in the July 24 issue of Morbidity and Mortality Weekly Report, recommendations are presented for testing and clinical management of health care personnel (HCP) exposed to the hepatitis C virus (HCV).
Financial Health of Hospitals ‘Dire’ Due to COVID-19
THURSDAY, July 23, 2020 (HealthDay News) — COVID-19 continues to cause financial peril for U.S. hospitals, according to a report released by the American Hospital Association (AHA).
U.K. Study Looks at Stepping Down Meds in Stable Asthma
TUESDAY, July 21, 2020 (HealthDay News) — Asthma patients are increasingly prescribed higher levels of treatment, and few patients step down medications, according to a study published online July 21 in PLOS Medicine.
Few Pediatricians Putting Peanut Allergy Guidelines Into Practice
THURSDAY, July 16, 2020 (HealthDay News) — Most pediatricians are aware of the 2017 Addendum Guidelines for the Prevention of Peanut Allergy in the United States, but less than one-third are fully implementing them, according to a study published online July 15 in JAMA Network Open.
Physical Distancing Interventions Cut Incidence of COVID-19
THURSDAY, July 16, 2020 (HealthDay News) — Physical distancing interventions are associated with a reduced incidence of COVID-19 globally, according to a study published online July 15 in The BMJ.
Global Population Anticipated to Peak in 2064
WEDNESDAY, July 15, 2020 (HealthDay News) — The global population is anticipated to peak in 2064 and then decline to year 2100, according to a study published online July 14 in The Lancet.
Poor Sleep Patterns May Up Risk for Attacks in Adults With Asthma
WEDNESDAY, July 15, 2020 (HealthDay News) — Too little sleep or too much sleep is tied to more asthma attacks in adults, according to a study recently published in the Annals of Allergy, Asthma & Immunology.
Layoffs Cost 5.4 Million Americans Their Health Insurance
TUESDAY, July 14, 2020 (HealthDay News) — About 5.4 million Americans lost their health insurance after being laid off between February and May due to the COVID-19 pandemic, a new study shows.
The New York Times Article
Maternal Allergy, Asthma Traits Up Child Risk in Early Years
MONDAY, July 13, 2020 (HealthDay News) — In early life, maternal history of allergies and asthma confers a stronger effect on a child’s risk for developing the same traits compared with the father’s history, according to a study published online July 7 in Clinical & Experimental Allergy.
Nemolizumab Beats Placebo for Reduction of Pruritus in Eczema
THURSDAY, July 9, 2020 (HealthDay News) — For patients with atopic dermatitis and moderate-to-severe pruritus, nemolizumab results in a greater reduction in pruritus than placebo, according to a study published in the July 9 issue of the New England Journal of Medicine.
Electronic Health Records Fail to Detect Many Medication Errors
THURSDAY, July 9, 2020 (HealthDay News) — There is wide variation in the safety performance of electronic health record (EHR) systems used in U.S. hospitals, according to a study recently published in JAMA Network Open.
Oral Corticosteroid Bursts Carry Risk for Severe Adverse Events
TUESDAY, July 7, 2020 (HealthDay News) — Prescriptions for oral steroid bursts are associated with a 1.8- to 2.4-fold increased risk for severe adverse events within the first month after initiation of drug therapy, according to a study published online July 7 in the Annals of Internal Medicine.
Health Expenditures Considerable for Asthma, COPD in U.S. Workers
MONDAY, July 6, 2020 (HealthDay News) — The annualized total medical expenditures for asthma and chronic obstructive pulmonary disease (COPD) are $7 billion and $5 billion among U.S. workers, respectively, according to research published in the July 3 issue of the U.S. Centers for Disease Control and Prevention Morbidity and Mortality Weekly Report.
Roughly 2 Million Americans Buy Prescriptions From Outside the Country
THURSDAY, July 2, 2020 (HealthDay News) — An estimated 1.5 percent of American adults purchase prescription medication from outside of the United States to save money, according to a study published online June 24 in JAMA Network Open.
Copyright © 2020 ScoutNews, LLC. All rights reserved.
